| Trial Identifier: | 216152 |
| Sponsor: | GlaxoSmithKline |
| Collaborator: |
Biomedical Advanced Research and Development Authority
Wellcome Trust
Global Antimicrobial Resistance Innovation Fund-(GAMRIF)
Bill and Melinda Gates Foundation
|
| Start Date: | September 2022 |
| Primary Completion Date: | September 2024 |
| Study Completion Date: | January 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Country | Location |
|---|---|
| Belgium | Edegem, Belgium, 2650 |
| Malawi | Blantyre, Malawi, N/A |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company